BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4864194)

  • 1. Antimicrobial therapy of experimental human leprosy (Myco. leprae) infection in the mouse foot pad.
    Gaugas JM
    Lepr Rev; 1967 Oct; 38(4):225-30. PubMed ID: 4864194
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitazoxanide is active against Mycobacterium leprae.
    Bailey MA; Na H; Duthie MS; Gillis TP; Lahiri R; Parish T
    PLoS One; 2017; 12(8):e0184107. PubMed ID: 28850614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice.
    Gelber RH; Henika PR; Gibson JB
    Lepr Rev; 1984 Dec; 55(4):341-7. PubMed ID: 6396475
    [No Abstract]   [Full Text] [Related]  

  • 4. The activity of a thiadiazole on Mycobacterium leprae.
    Levy L
    Proc Soc Exp Biol Med; 1976 Oct; 153(1):34-6. PubMed ID: 792890
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
    Holmes IB
    Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug resistance in leprosy.
    Matsuoka M
    Jpn J Infect Dis; 2010 Jan; 63(1):1-7. PubMed ID: 20093754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
    Shepard CC; Van Landingham RM; Walker LL; Good RC
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):322-7. PubMed ID: 3298478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New prospects for the study of leprosy in the laboratory.
    Rees RJ
    Bull World Health Organ; 1969; 40(5):785-800. PubMed ID: 4898388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dihydrofolate reductase inhibitors on Mycobacterium Leprae in the mouse foot pad.
    Gelber RH; Levy L
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):124-32. PubMed ID: 776847
    [No Abstract]   [Full Text] [Related]  

  • 11. Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compounds.
    Balakrishnan S; Mester L; Venkataramaniah HN; Bhatia VN
    Indian J Lepr; 1985; 57(2):323-8. PubMed ID: 3908578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy.
    Levy L
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of enhancing effect of trimethoprim on the activity of a sulfonamide against Mycobacterium leprae.
    Pattyn SR; Verdoolaege-Van Loo G
    Int J Lepr Other Mycobact Dis; 1972; 40(3):320. PubMed ID: 4574275
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment].
    Ferracci C; Baquillon G; Pattyn SR
    Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ofloxacin against Mycobacterium leprae in the mouse.
    Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antibacterial drugs on the ultrastructure of Mycobacterium leprae in human skin.
    Edwards RP; Draper GJ; Draper P
    Lepr Rev; 1972 Dec; 43(4):173-80. PubMed ID: 4579978
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.
    Shepard CC
    Lepr Rev; 1981 Dec; 52(4):299-308. PubMed ID: 7031389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.